Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Steven Tian
Steven Tian is the director of research at the Yale Chief Executive Leadership Institute.
Page 2 of 5
Commentary
We led some of America’s largest companies. Here’s why we are voting for Harris, not Trump
By
Doug Parker
,
Reid Hoffman
, and others
Commentary
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Biden-Harris have a track record of real success in bringing manufacturing back to America. Trump’s all-sticks-no-carrots approach already failed
By
Jeffrey Sonnenfeld
,
Laura Tyson
, and others
Commentary
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
After 2 years of peddling Putin’s propaganda, the IMF is returning to Russia in open defiance of the West
By
Jeffrey Sonnenfeld
,
Tymofiy Mylovanov
, and others
Commentary
Brian Niccol may well be the messiah Starbucks—and Howard Schultz—have been looking for
By
Jeffrey Sonnenfeld
,
Stephen Henriques
, and others
Commentary
The WSJ’s Evan Gershkovich had his employer’s support—but that’s not always the case for employees on an overseas mission
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
The ‘Trump Dump’ is back—and the stocks that he targets are crashing
By
Jeffrey Sonnenfeld
,
Whitney Tilson
, and others
Commentary
200 top CEOs reveal how AI is already transforming their sectors at Yale summit
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Activist investors are suffering grueling defeats in proxy fights—but they can still matter when they pick the right battle
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Norfolk Southern is getting back on track–but activist investor Ancora is trying to derail it in a vicious proxy fight
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Why Bob Iger’s strategy for the next decade of growth at Disney promises a magic carpet ride for the Magic Kingdom’s future
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Inside the cockpit at Boeing: Here are the top 5 candidates for CEO as Dave Calhoun exits
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
The latest sanctions on Russia won’t be sufficient. Here’s what would be, according to the Yale professor who inspired the great business exodus over Ukraine
By
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Nelson Peltz is America’s most overrated activist investor. Here’s what the experts missed about his performance
By
Jeffrey Sonnenfeld
and
Steven Tian